Subscribe to Newsletter

Content by Stephanie Vine:

Manufacture Vaccines

Searching for a Syphilis Vaccine

| Stephanie Vine

How whole genome sequencing is being used to understand the bacterium that causes syphilis – and what it means for vaccine development.

Business & Regulation Standards & Regulation

FDA Warning Letters: September 2024 Edition

| Stephanie Vine | 3 min read

Here’s a look at recent violations cited in FDA Warning Letters: fly pupae, cross contamination, trial dosing errors, and more.

Business & Regulation Trends & Forecasts

The Multifaceted Future of Pharma

| Stephanie Vine

We asked over 100 industry professionals for their views on the future of the pharma and biopharma industries.

Business & Regulation Profession

Words of Wisdom

| Stephanie Vine

A look back at some of the most inspiring quotes from our interviews.

Manufacture Technology and Equipment

The Nonprofit Model for Manufacturing

| Stephanie Vine | 13 min read

Civica Rx is approaching generic drug manufacturing using a nonprofit model – and it’s working. We get the story behind their facility in Petersburg.

Business & Regulation Supply Chain

Weight Loss Fakers

| Stephanie Vine

Researchers purchase Ozempic online and test for authenticity. Yes, it was counterfeit.

Business & Regulation Standards & Regulation

EMA: No to Lecanemab

| Stephanie Vine | 3 min read

Lecanemab is refused marketing authorization by the European Medicines Agency.

Business & Regulation Standards & Regulation

The Choice: To Be Cured or to Have Children?

| Stephanie Vine

Fertility support programs for gene therapy Medicare patients are being blocked in the US.

Manufacture Advanced Medicine

TILs Taking on Solid Tumors

| Stephanie Vine | 10 min read

An interview on the development of Amtagvi – the world’s first approved T-cell therapy for a solid tumor.

Business & Regulation Trends & Forecasts

Dystopia or Utopia? Contribute to our Special Feature on the Future of Pharma

| Stephanie Vine | 4 min read

Contribute to our special feature celebrating the future of pharma.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register